Photo: Nir Elias/Reuters/Landov
Eyal Baror, the CEO of Neur1onix, stands behind his company’s product—a system that helps treat people with Alzheimer’s disease. The noninvasive medical device, which combines electromagnetic stimulation with computer-based cognitive training, has boosted the cognitive functioning of patients in an ongoing U.S. trial. “We see improvement lasting for 9 to 12 months, and the good thing is that patients can return and undergo treatment again,” says Baror. It has already been approved for use in Europe and Israel.










If you are viewing this page with an iPad or iPhone, click here to launch the slideshow:
Willie Jones
Willie Jones is an associate editor at IEEE Spectrum. In addition to editing and planning daily coverage, he manages several of Spectrum's newsletters and contributes regularly to the monthly Big Picture section that appears in the print edition.
The Conversation (0)